| Best Practice || > About > Best Practice
Principles of transparency and best practice
i. The URL address of official journal web site is http://e-cacd.org.
ii. 'Aims & Scope' statement:
Clinical Archives of Communication Disorders (CACD) publishes peer-reviewed research and other scholarly articles on normal and abnormal processes. The journal is an international channel for both basic research on communication processes and clinical research pertaining to the screening, diagnosis, and management of communication disorders; as well as their etiologies and characteristics. CACD seeks to not only advance evidence-based practice by disseminating the results of new studies but also to provide a forum for critical reviews and meta-analyses of previously published work.
This journal is primarily for professionals who work in the area of communication sciences and disorders. They will be able to obtain tailored information to adopt for their workplace
Its readership can be expanded to other positions:
• Researchers can access cases of adoption of theories and evidence-based practices;
• Professors of communication sciences and disorders can access and adopt a variety of data for education;
• Clinicians in the field can access new theoretical and practical information to adopt for their work.
• Students can discover recent trends and tools so that they are able to adapt to the new practical environment and recent clinical methods.
• The public will be able to read about he advancement in human communications and science of disorders.
iv. Authorship criteria:
Authorship should be credited to those who have had direct involvement in the study and who fulfill the following criteria: (a) made significant contributions to either the conception or design of, or data collection, analyses and/or interpretation for, the work; AND (b) drafted the work or undertook critical revisions for important intellectual content; AND (c) approved the final version for publication. The primary investigator is designated as the first author of the study, unless contested by the other authors.
The corresponding author is directly responsible for communication about and revision of the submitted manuscript. In the case of a change in authorship, a written explanation must be submitted; changes to either the first or corresponding author(s) require approval by the editorial board.
v. Duplicate submission and redundant publication:
Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. Submitted manuscripts are screened for possible plagiarism or duplicate publication by CrossCheck upon arrival. If plagiarism or duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutions will be informed. There will also be penalties for the authors. A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, figures, and tables.
2. Name of journal
The official journal title is Clinical Archives of Communication Disorders. Abbreviated title is Clin Arch Commun Disord.
3. Peer review process
CACD reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript meets these two criteria. It is checked for plagiarism or duplicate publication with Similarity Check. After confirming its result, it is dispatched to three investigators in the field with relevant knowledge. Once the manuscript is sent to reviewers, CACD waits to receive opinions from at least two reviewers. In addition, if deemed necessary, a review of statistics may be requested. The authors’ names and affiliations are removed during peer review (double-blind peer review). The acceptance criteria for all papers are based on the quality and originality of the research and its scientific significance. Acceptance of the manuscript is decided based on the critiques and recommended decision of the reviewers. An initial decision will normally be made within 4 weeks of receipt of a manuscript, and the reviewers’ comments are sent to the corresponding author by e-mail. The corresponding author must indicate the alterations that have been made in response to the reviewers’ comments item by item. Failure to resubmit the revised manuscript within 4 weeks of the editorial decision is regarded as a withdrawal. If further revision period is required, the author should contact the editorial office through form mail, available from: http://www.e-cacd.org/about/contact.php. A final decision on acceptance/rejection for publication is forwarded to the corresponding author from the editor.
i. Information about ownership: This journal is owned by the publisher, the Korean Association of Speech-Language Pathologists (K-SLP) http://www.kslp.org/.
ii. Management team
Journal management team (2017~2019)
- Journal manager: Yaelin Choi (Myungji University, Korea)
- Manager of Review process: Jin Ah Jeon (Hallym University, Korea)
- Ethics Editor: Gyoung Yuel Lim (Honam University, Korea)
- Statistics Editor: Song Yong Sim (Hallym University, Korea)
- Manuscript Editor: Jaeock Kim(Gangnam University, Korea)
- English Editor: Jenny Jackson-Smith (Lee & Lee Speech and Language Clinics, Korea)
- Layout Editor: MiKyoung Kim (Academya Publishing Co., Editing print publication, Korea)
- Website and JATS XML File Producers: Yoonsang Cho, Minyoung Choi (M2community, Korea)
5. Governing body
The governing body is the journal's editorial board.
6. Editorial team and contact information
Samuel Do-Heung Ko (Hallym Univeristy, Korea)
Brooke Hallowell (Springfield College, USA)
In-Sop Kim (Northern Illinois University, USA)
Youngsun Kim (Ohio University, USA)
Rajinder Koul (University of Texas-Austin, USA)
Malcolm McNeil (University of Pittsburgh, USA)
Sheila Pratt (University of Pittsburgh, USA)
Ralf Schlosser (Northeastern University, USA)
John A. Seikel (Idaho State University, USA)
Yang-soo Yoon (Baylor University, USA)
Lisa R. Audet (Kent State University, USA)
Devender R. Banda (Texas Tech University, USA)
Juan Bornman (University of Pretoria, South Africa)
Sheng Hwa Chen (Asia University, TAIWAN)
Yaelin Choi (Myongji Univesity, Korea)
Melinda D. Corwin (Texas Tech University HSC, USA)
Neila J. Donovan (Louisiana State University, USA)
Heidi M. Harbers (Illinois State University, USA)
Jerry K. Hoepner (University of Wisconsin-Eau Claire, USA)
Julie Jeon (University of Utah, USA)
Jack Jiang (University of Wisconsin-Madison, USA)
Margaret Kjelgaard (Marymount Manhattan College, USA)
Esther S. Kim (University of Alberta, Canada)
Jaeok Kim (Kangnam University, Korea)
YunJung Kim (Louisiana State University, USA)
Anthony Pak Hin Kong (University of Central Florida, USA)
Kyoung Yuel Lim (Honam University, Korea)
John McCarthy (Ohio University, USA)
Taeok Park (Illinois State University, USA)
Rubini Pasupathy (Texas Tech University HSC, USA)
Melissa Randazzo (Adelphi College, USA)
Dada Shakila (University of Pretoria, South Africa)
Jeff Sigafoos (Victoria University of Wellington, New Zealand)
Pamela A. Smith (Bloomsburg University, USA)
Ji Hye Yoon (Hallym University, Korea)
Jennifer B. Watson (Texas Christian University, USA)
Jin Ah Jeon (Hallym University, Korea)
Gyoung Yuel Lim (Honam University, Korea)
Song Yong Sim (Hallym University, Korea)
Gyoung Yuel Lim (Honam University, Korea)
Jaeock Kim (Gangnam University, Korea)
Yong Hoon Choo (Academya Publishing Co., Editing print publication, Korea)
MiKyoung Kim (Academya Publishing Co., Editing print publication, Korea)
Website and JATS XML File Producers
Yoonsang Cho (M2community Co.,Korea)
Minyoung Choi (M2community Co.,Korea)
Contact information http://www.e-cacd.org/about/contact.php
Editor-in-Chief: Samuel Do-Heung Ko, Ph.D.
The Korean Association of Speech-Language Pathologists
#409, 102 SK-Hub BULD, 461 Samil-daero, Jongno-gu, Seoul 03147, Korea
7. Copyright and Licensing
i. Copyright policy: All published papers become the permanent property of the Korean Association of Speech-Language Pathologists (K-SLP). Copyrights of all published materials are owned by K-SLP. Permission must be obtained from K-SLP for any commercial use of materials. Every author should sign the copyright transfer agreement forms.
ii. Licensing information: This is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose (http://creativecommons.org/licenses/by-nc/4.0/).
iii. Deposit policy: According to the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk/), authors cannot archive pre-print (i.e. pre-refereeing), but they can archive post-print (i.e. final draft post-refereeing). Authors can archive publisher's version/PDF.
8. Author fees
No page charge or article processing charge applies. There is also no submission fee. It is a platinum open access journal which means there is no author-side fee.
9. Process for the identification of and dealing with allegations of research misconduct
When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on; the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.
10. Publication Ethics
i. Journal policies on authorship and contributorship
Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Every author should meet all of these four conditions. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
Corresponding author and first author: CACD does not allow multiple corresponding authors for one article. Only one author should correspond with the editorial office and readers for one article. CACD does accept notice of equal contribution for the first author when the study was clearly performed by co-first authors.
Correction of authorship after publication: CACD does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication but after submission when an authorship correction is requested by all of the authors involved with the manuscript.
ii. How the journal will handle complaints and appeals: The policy of the journal is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal. If not described below, the process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics available from: https://publicationethics.org/appeals
Who complains or makes an appeal?
Submitters, authors, reviewers, and readers may register complaints and appeals in a variety of cases as follows: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problem. If any individuals or institutions want to inform CACD regarding any improprieties, they can send a letter to the editor For complaints or appeals, concrete data with answers to all factual questions (who, when, where, what, how, why) should be provided.
iii. Journal policies on conflicts of interest / competing interests
The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.
iv. Journal policies on data sharing and reproducibility;
Open data policy
For clarification on result accuracy and reproducibility of the results, raw data or analysis data will be deposited to a public repository, for example, Harvard Dataverse (https://dataverse.harvard.edu/dataverse/) after acceptance of the manuscript. Therefore, submission of the raw data or analysis data is mandatory. If the data is already a public one, its URL site or sources should be disclosed. If data cannot be publicized, it can be negotiated with the editor. If there are any inquiries on depositing data, authors should contact the editorial office.
Clinical data sharing policy
This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement as described below. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial's registration. The ICMJE's policy regarding trial registration is explained at https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit data sharing plan of example 1 to 4 in Table 1. Based on the degree of sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site.
Table 1. Examples of data sharing statements that fulfill these ICMJE requirements*
|Will individual participant data be available (including data dictionaries)?
|What data in particular will be shared?
||All individual participant data collected during the trial, after deidentification.
||Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
||Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
|What other documents will be available?
||Study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code
||Study protocol, statistical analysis plan, analytic code
|When will data be available (start and end dates)?
||Immediately following publication. No end date.
||Beginning at 3 months and ending at 5 years following the article publication.
||Beginning at 9 months and ending at 36 months following the article publication.
||Anyone who wishes to access the data.
||Researchers who provide a methodologically sound proposal.
||Investigators whose proposed use of the data has been approved by an independent review committee (“learned intermediary”) identified for this purpose.
|For what types of analyses?
||To achieve aims in the approved proposal.
||For individual participant data meta-analysis.
|By what mechanism will data be made available?
||Data are available indefinitely at (link to be included).
||Proposals should be directed to xxx@yyy. To gain access, data requestors will need to sign a data access agreement.
||Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata.
||Data are available for 5 years at a third-party website (link to be included).
||Information regarding submitting proposals and accessing data may be found at (link to be provided).
ICMJE = International Committee of Medical Journal Editors.
*These examples are meant to illustrate a range of, but not all, data sharing options.
v. Journal's policy on ethical oversight:
When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues; the resolving process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The Editorial Board will discuss the suspected cases and reach a decision. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
vi. Journal's policy on intellectual property:
All published papers become the permanent property of the the Korean Association of Speech-Language Pathologists (K-SLP). Copyrights of all published materials are owned by K-SLP.
vii. Journal's options for post-publication discussions and corrections:
The post-publication discussion is available through letter to editor. If any readers have a concern on any articles published, they can submit letter to editor on the articles. If any errors or mistakes are found in the article, they can be corrected through errata, corrigenda, or retraction.
11. Publishing schedule
This journal will be published three times a year. Supplement issues may be published.
This is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Is is accessible without barrier from National Library of Korea (http://nl.go.kr) in the event a journal is no longer published.
14. Revenue sources
Revenue sources of this journal are the Korean Association of Speech-Language Pathologists, the Korean Government, and advertising revenue.
CACD accepts advertisements on the following basis:
1. Eligibility of the advertised products or services
All products or services should be safe and reliable, and not cause any harm to the health and welfare of humans. Advertisements may promote information and technologies relevant for authors, editors, reviewers, and readers. Pharmaceutical products may also be considered.
Any individuals or organizations who are interested in advertising their products or services in this journal are encouraged to contact the editorial office. The acceptance of advertisement will be discussed by the editorial board and will be ultimately approved by the publisher.
3. Advertisement fee
For banner advertisements on the website, the price is negotiable according to the duration of its exposure on the journal homepage.
Liability: Neither the publisher nor the editors will be legally liable for advertisements presented in the journal. In addition, they cannot guarantee the accuracy, completeness, or usefulness of the information provided.
Endorsement: The publisher and the editors do not endorse any products or services that are advertised.
Disclaimer: Neither the publisher nor the authors will be legally liable for any of the content of advertisements, so readers must keep this in mind when reading or seeing advertisements.
16. Direct marketing
Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.